Key Issues Discussed with WHO Department Representatives

During his business trip to India, the Director of the Center for Pharmaceutical Products Safety, Alisher Temirov, held an important meeting with Hitti B. Sillo, Head of the Regulation and Safety Unit at the Department of Regulation and Prequalification at WHO.

A number of key issues were discussed at the meeting, including support for the benchmarking process in the activities of The Center for Pharmaceutical Products Safety by the World Health Organization, as well as the possibilities for prequalifying the Center's laboratories by WHO. Particular attention was paid to the introduction of international standards to ensure the safety of pharmaceutical products and the exchange of experiences.

During the meeting, the organization of training sessions and seminars on relevant topics for the Center’s staff was also raised. It was noted that these seminars and training sessions, aimed at improving staff qualifications and sharing the latest developments and experiences in the field, are planned to be conducted in collaboration with WHO. This will further strengthen the Center's ability to operate in accordance with international standards.

The technical assistance provided by WHO to the Center, as well as the certification of our laboratories according to international requirements, is expected to significantly contribute to the rapid development of the pharmaceutical sector in our country. As Alisher Temirov emphasized, this cooperation is important not only for improving the national pharmaceutical safety system but also for the regional system as a whole.

In conclusion, it was agreed to further develop close cooperation with the WHO, as well as to work together on improving the processes of pharmacovigilance and the registration of pharmaceutical products in accordance with international requirements.